The Six Most Common Mistakes in Migraine Management
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- What are the most common barriers that prevent people from gaining better control of their migraine?
- What are the most common errors you see in acute migraine treatment, and what practical strategies do you recommend?
- What are common challenges in preventive treatment, and how can they be addressed?
- What underlying issues often go untreated and keep migraine in a chronic state?
- How do medication overuse and neck pain feed into chronic migraine?
- What risks are associated with an overavoidant or hypervigilant approach to migraine triggers?
- How can patients and clinicians collaborate to identify and address invisible barriers?
- What are the key components of an effective long-term migraine management plan?
Interview Notes
- Yellow Rose Headache and Neuro-Ophthalmology, PLLC
- Study: “Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors”
- Study: “Defeating migraine pain with triptans: A race against the development of cutaneous allodynia”
- Study: “Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization”
- The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
- Migraine Disability Assessment Test
- 2019 Migraine World Summit: Diagnosing Pressure Headaches vs. CSF Leaks
Treatments Mentioned
- Acetaminophen/Paracetamol
- Butalbital
- CGRP monoclonal antibodies (mAbs)
- CGRP small-molecule receptor antagonists (gepants)
- Cognitive behavioral therapy (CBT)
- Ergotamine derivatives
- GLP-1 agonists
- Headache diary
- Neuromodulation devices
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- OnabotulinumtoxinA (Botox)
- Opioids
- Sleep specialist (somnologist)
- Triptans
Find 300+ treatments in our full Treatment Directory — available with a VIP Access Pass.
For additional links and resources, click here.
Disclaimer: The Migraine World Summit aims to bring you a variety of perspectives and expertise, free from bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan. Captions are auto-generated and may contain errors.
Deborah Friedman, MD, MPH, FAAN, FAHS
Neuro-Ophthalmologist & Headache Specialist
Yellow Rose Headache & Neuro-Ophthalmology
Dr. Deborah Friedman is a neurologist specializing in headache medicine and neuro-ophthalmology. She practices at Yellow Rose Headache and Neuro-Ophthalmology in Dallas.
Dr. Friedman was the founding director of the Headache and Facial Pain Program and the Cerebrospinal Fluid Dynamics Program at the University of Texas Southwestern Medical Center. She is board certified in neurology and headache medicine. Additionally, she is a fellow of the American Academy of Neurology, the American Headache Society (AHS), the American Neurological Association, and the North American Neuro-Ophthalmology Society (NANOS).
She served on the board of directors for the AHS, is the president-elect for the Southern Headache Society, is a past president of the North American Neuro-Ophthalmology Society (NANOS), and is on the steering committee for the Idiopathic Intracranial Hypertension (IIH) Treatment Trial, which represents the largest prospectively analyzed cohort of untreated patients with IIH. She has published over 140 articles in peer-reviewed journals and 27 book chapters. Her key interests are intracranial pressure disorders, migraine, and cluster headache.
Interviews from Deborah Friedman, MD, MPH, FAAN, FAHS
The Six Most Common Mistakes in Migraine Management
When Headache Starts Behind the Eyes
Latest Migraine Treatment Landscape
The Latest New Treatments for Migraine
Light Sensitivity and Therapy for Migraine
Common Traps of Chronic Migraine
Diagnosing Pressure Headaches vs. CSF Leaks
Research Pipeline: New Migraine Therapies in Development
Cluster Headache
Understanding & Treating Migraine in Older Adults
Go Beyond the Free Summit Interviews
- Full-length expert interviews beyond the 30-minute edits
- Revisit any 2026 session anytime
- Transcripts and audio downloads included
- Review insights before medical appointments
Related Talks for: Day 1 (2026)
You’re Not Imagining It: Migraine’s Strange Symptoms Explained
Jessica Ailani, MD, FAHS, FAAN
What Everyone With Migraine Should Know About Gut Health
Robert Bonakdar, MD
GLP-1s, Obesity & Migraine
Aarushi Suneja, MD
The American Migraine Foundation (AMF) is a non-profit organization dedicated to the advancement of research and awareness surrounding migraine, a disabling condition that impacts more than 37 million men, women and children in the United States. The AMF was founded in 2010 to provide global access to information and resources for individuals with migraine as well as their family and friends.
Pfizer's purpose is breakthroughs that change patients’ lives. We pursue that goal relentlessly and innovate every day to make the world a healthier place. It was Charles Pfizer’s vision at the beginning and it holds true today.
The Migraine World Summit starts today! Get a free text reminder so you don’t miss a moment. Sign up now to receive key updates during the event. Available in the U.S., Canada, U.K., and Australia—enter your mobile number now!
